Ferdinando Raimondi
About
In The Last Decade
Ferdinando Raimondi
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 100
- Pulmonary and Respiratory Medicine 424
- Critical Care and Intensive Care Medicine 308
- Cardiology and Cardiovascular Medicine 216
- Epidemiology 211
- Emergency Medicine 194
Countries citing papers authored by Ferdinando Raimondi
This map shows the geographic impact of Ferdinando Raimondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinando Raimondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinando Raimondi more than expected).
Fields of papers citing papers by Ferdinando Raimondi
This network shows the impact of papers produced by Ferdinando Raimondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinando Raimondi. The network helps show where Ferdinando Raimondi may publish in the future.
Co-authorship network of co-authors of Ferdinando Raimondi
This figure shows the co-authorship network connecting the top 25 collaborators of Ferdinando Raimondi. A scholar is included among the top collaborators of Ferdinando Raimondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdinando Raimondi. Ferdinando Raimondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 7 | |
| 3 | 13 | |
| 4 | 13 | |
| 5 | 8 | |
| 6 | 14 | |
| 7 | 126 | |
| 8 | 29 | |
| 9 | 24 | |
| 10 | 27 | |
| 11 | 16 | |
| 12 | A novel hepatocyte nuclear factor-1β (MODY 5) gene mutation in a Romanian boy with pancreatic calcifications, renal and hepatic dysfunction. | 3 |
| 13 | 7 | |
| 14 | 13 | |
| 15 | 354 | |
| 16 | Italy versus the United Kingdom: differing styles for treating bacteremia in the critically ill patient, but who's right? | 2 |
| 17 | 18 | |
| 18 | 44 | |
| 19 | 28 | |
| 20 | [Indications, clinical implications and limitations in the use of a severity of illness index in intensive therapy]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.